A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination
Guan‐Jhou Chen(National Taiwan University Hospital), Chien‐Ching Hung(National Taiwan University), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Yu‐Shan Huang(Capital Medical University), Wang-Da Liu(National Taiwan University Hospital), Un‐In Wu(National Taiwan University Hospital), Hsin‐Yun Sun(National Taiwan University Hospital), Yu‐Chung Chuang(National Taiwan University Hospital), Sung‐Ching Pan(National Taiwan University Hospital), Aristine Cheng(Far Eastern Memorial Hospital), Szu‐Min Hsieh(National Taiwan University), Cheng-Hsin Wu(National Taiwan University Hospital), Yi‐Ching Su(National Taiwan University Hospital), Wen‐Chun Liu(National Taiwan University Hospital), Yi‐Chia Huang(National Taiwan University Hospital), Kuan‐Yin Lin(National Taiwan University)
Cited by 9
Related Papers
Animal models for COVID-19
|Nature|2020|877
Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure
|Journal of Bacteriology|1987|512
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics
|Nature Biomedical Engineering|2021|433
Prolonged virus shedding even after seroconversion in a patient with COVID-19
|Journal of Infection|2020|302